Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 Feb;10(2):324-30.
doi: 10.1111/j.1600-6143.2009.02954.x. Epub 2010 Jan 5.

Pathological and clinical characterization of the 'troubled transplant': data from the DeKAF study

S Gourishankar  1 , R Leduc, J Connett, J M Cecka, F Cosio, A Fieberg, R Gaston, P Halloran, L Hunsicker, B Kasiske, D Rush, J Grande, R Mannon, A Matas
Affiliations

Pathological and clinical characterization of the 'troubled transplant': data from the DeKAF study

S Gourishankar et al. Am J Transplant. 2010 Feb.

Abstract

We are studying two cohorts of kidney transplant recipients, with the goal of defining specific clinicopathologic entities that cause late graft dysfunction: (1) prevalent patients with new onset late graft dysfunction (cross-sectional cohort); and (2) newly transplanted patients (prospective cohort). For the cross-sectional cohort (n = 440), mean time from transplant to biopsy was 7.5 +/- 6.1 years. Local pathology diagnoses included CAN (48%), CNI toxicity (30%), and perhaps surprisingly, acute rejection (cellular- or Ab-mediated) (23%). Actuarial rate of death-censored graft loss at 1 year postbiopsy was 17.7%; at 2 years, 29.8%. There was no difference in postbiopsy graft survival for recipients with versus without CAN (p = 0.9). Prospective cohort patients (n = 2427) developing graft dysfunction >3 months posttransplant undergo 'index' biopsy. The rate of index biopsy was 8.8% between 3 and 12 months, and 18.2% by 2 years. Mean time from transplant to index biopsy was 1.0 +/- 0.6 years. Local pathology diagnoses included CAN (27%), and acute rejection (39%). Intervention to halt late graft deterioration cannot be developed in the absence of meaningful diagnostic entities. We found CAN in late posttransplant biopsies to be of no prognostic value. The DeKAF study will provide broadly applicable diagnostic information to serve as the basis for future trials.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Post-biopsy slope of 1/creatinine vs. time for recipients in the cross-sectional cohort. (The dots are the pointwise means from the raw data and the error bars mark out ± 2 SD from the means. The curve shows the average change of serum creatinine over time; note that there is a difference in slope before and after 6 months.)
Figure 2
Figure 2
Graft survival after biopsy for recipients with vs. without chronic allograft nephropathy (CAN) (P=NS)
See this image and copyright information in PMC

References

    1. Matas AJ, Humar A, Payne WD, Gillingham KJ, Dunn DL, Sutherland DE, et al. Decreased acute rejection in kidney transplant recipients is associated with decreased chronic rejection. Ann Surg. 1999;230:493–498. - PMC - PubMed
    1. Hariharan S, Johnson CP, Bresnahan BA, Taranto SE, McIntosh MJ, Stablein D. Improved graft survival after renal transplantation in the United States, 1988 to 1996. N Engl J Med. 2000;342:605–612. - PubMed
    1. Hariharan S, McBride MA, Cherikh WS, Tolleris CB, Bresnahan BA, Johnson CP. Post-transplant renal function in the first year predicts long-term kidney transplant survival. Kidney Int. 2002;62:311–318. - PubMed
    1. Gourishankar S, Hunsicker LG, Jhangri GS, Cockfield SM, Halloran PF. The stability of the glomerular filtration rate after renal transplantation is improving. J Am Soc Nephrol. 2003;14(9):2387–2394. - PubMed
    1. Kasiske BL, Gaston RS, Gourishankar S, Halloran PF, Matas AJ, Jeffery J, et al. Long-term deterioration of kidney allograft function. Am J Transplant. 2005;5(6):1405–1414. - PubMed